Abstract
Introduction
Moyamoya disease (MMD) is an extremely rare neurovascular disorder in Caucasian children. To the best of our knowledge, the aggressive variant including hemorrhagic malignant stroke and consecutive global ischemia has not been reported for this population before.
Case report
We present the case of an 11-year-old girl with sudden neurological deterioration due to intracerebral hemorrhage with early irruption into the ventricular system. MMD with extensive neovascularization was diagnosed by means of computed tomography and magnetic resonance imaging. Despite immediate ventricular drainage, intracranial pressure increased above the mean arterial pressure resulting in malignant bi-hemispheric ischemia. The girl died within 53 h after admission to hospital.
Discussion
Intracerebral hemorrhage in young patients is often attributed to vascular malformation. This case shows that MMD may constitute a potential diagnosis in the case of sudden neurological deterioration and loss of consciousness, even in previously healthy children.
Similar content being viewed by others
References
Ahn JH, Wang KC, Phi JH, Lee JY, Cho BK, Kim IO, Kim SK (2012) Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Childs Nerv Syst 28:237–245
Ayer RE, Zhang JH (2008) The clinical significance of acute brain injury in subarachnoid hemorrhage and opportunity for intervention. Acta Neurochir Suppl 105:179–184
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307
Chiu D, Shedden P, Bratina P, Grotta JC (1998) Clinical features of moyamoya disease in the United States. Stroke 29:1347–1351
Dusick JR, Gonzalez NR, Martin NA (2011) Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68:34–43, discussion 43
Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, Mikulis DJ, Tymianski M (2011) Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42:3047–3054
Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M (1997) Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99(Suppl 2):S6–S10
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81:673–678
Kim DS, Jang DK, Huh PW, Yoo DS, Han YM, Huh CW (2011) Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease: six new cases and a short literature review. Acta Neurochir (Wien) 153:1253–1261
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101
King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, Alleyne CH, Dhandapani KM (2010) Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 28:E10
Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47
Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J (2012) Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 84(3):258–265
Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965–976
Nishimoto A, Takeuchi S (1968) Abnormal cerebrovascular network related to the internal cartoid arteries. J Neurosurg 29:255–260
Oshima H, Katayama Y (2012) Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s. Childs Nerv Syst 28:497–500
Pandey P, Steinberg GK (2011) Neurosurgical advances in the treatment of moyamoya disease. Stroke 42:3304–3310
Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim WC, Kim OJ, Kim TG, Choi JU, Kim DS, Kim NK (2012) The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7:e47158
Rafay MF, Smith SE, Dirks P, Armstrong D, deVeber GA (2006) Hemorrhage predisposing to cerebral infarction in children with moyamoya disease. Pediatr Neurol 34:400–404
Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J (2008) MMP-9-positive neutrophil infiltration is associated to blood–brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39:1121–1126
Suzuki J, Kodama N (1983) Moyamoya disease—a review. Stroke 14:104–109
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299
Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR (2011) Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 30:E20
Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y (1999) Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-Up study. Stroke 30:2272–2276
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schödel, P., Brawanski, A., Friedrich, M. et al. Fatal hemorrhagic stroke in a Caucasian girl with moyamoya disease. Childs Nerv Syst 29, 1381–1385 (2013). https://doi.org/10.1007/s00381-013-2089-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-013-2089-5